Safety, Tolerability, and Pharmacokinetics of ASC43F, a Fixed Dose Combination Tablet in Healthy Subjects
Clinical trial NCT05118516 · COMPLETED
Trial details
- NCT number
- NCT05118516
- Sponsor
- Gannex Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-01
- Primary completion
- 2021-12-07
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.